This
Note may be issued with original issue discount (“OID”) for U.S. Federal income tax purposes. THE AMOUNT OF OID SHALL
BE MUTUALLY DETERMINED BY THE ORIGINAL HOLDER AND THE COMPANY IN GOOD FAITH AND IN ACCORDANCE WITH THE APPLICABLE PROVISIONS OF
SECTIONS 1271 THROUGH 1275 OF THE U.S. INTERNAL REVENUE CODE. The issue price, amount of OID, issue date and yield to maturity
with respect to this Note may be obtained by writing to the Borrower at the following address: 209 Perry parkway, suite 7, gaithersburg,
md 20877; Attention: steven a. shallcross, CHIEF FINANCIAL OFFICER, Fax Number: (240) 499-2690; ELECTRONIC MAIL: ________@__________.COM.


 


THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION UNDER SAID ACT INCLUDING, WITHOUT LIMITATION, PURSUANT TO RULES 144 OR 144A UNDER SAID ACT OR PURSUANT TO A PRIVATE
SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4(1) AND A HALF”
SALE.


 


THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN REGISTRATION RIGHTS AGREEMENT DATED AS OF SEPTEMBER __,
2012, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH AGREEMENT
MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY.


 


SENIOR SECURED CONVERTIBLE NOTE


 


	Issuance Date:   March 31, 2014	Principal:  U.S. $[_____________]


 


FOR VALUE RECEIVED,
CYTOMEDIX, INC., a Delaware corporation (the “Company”), hereby promises to pay to [_____________________],
or its registered assigns (the “Holder”) the principal amount of [_____________________] Dollars ($[__________])
(the “Principal”) pursuant to, and in accordance with, the terms of that certain Facility Agreement, dated
as of March 31, 2014, by and among the Company and the Lenders party thereto (together with all exhibits and schedules thereto
and as may be amended, restated, modified and supplemented from time to time, the “Facility Agreement”). The
Company hereby promises to pay accrued and unpaid Interest (as defined below) and premium, if any, on the Principal on the dates,
at the rates and in the manner provided for in the Facility Agreement. This Senior Secured Convertible Note (including all Senior
Secured Convertible Notes issued in exchange, transfer or replacement hereof, and as any of the foregoing may be amended, restated,
supplemented or otherwise modified from time, this “Note”) is one of the Senior Secured Convertible Notes issued
pursuant to the Facility Agreement (collectively, including Senior Secured Notes to be issued pursuant to the Facility Agreement
in the future, all Senior Secured Convertible Notes issued in exchange, transfer or replacement thereof, and as any of the foregoing
may be amended, restated, supplemented or otherwise modified from time to time, the “Notes”). All capitalized
terms used and not otherwise defined herein shall have the respective meanings set forth in the Facility Agreement.


 




    	 



    	 



    

 


This Note is subject
to mandatory prepayment on the terms specified in the Facility Agreement. Except as expressly provided in the Facility Agreement,
the Company has no right, but under certain circumstances may have an obligation, to make payments of Principal prior to the Final
Payment Date. At any time an Event of Default exists, the Principal of this Note, together with all accrued and unpaid Interest
and any applicable premium due, if any, may be declared, or shall otherwise become, due and payable in the manner, at the price
and with the effect provided in the Facility Agreement.


 


1.          Definitions.


 


(a)          Certain
Defined Terms. For purposes of this Note, the following terms shall have the following meanings:


 


(i)          “Affiliate”
means any person or entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is
under common control with a person or entity, as such terms are used in and construed under Rule 144 under the Securities Act.
With respect to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment
manager as such Holder will be deemed to be an Affiliate of such Holder. As used in this definition of “Affiliate,”
the term “control” means the possession and policies of a Person, whether through ownership of voting securities or
partnership or other ownership interest, by contract, or otherwise.


 


(ii)         “Common
Stock” means the common stock, par value $0.0001 per share, of the Company.


 


(iii)        “Conversion
Amount” means the sum of (A) the Principal to be converted, redeemed or otherwise with respect to which this determination
is being made and (B) the amount of all accrued and unpaid Interest on the Principal to be converted, redeemed or otherwise with
respect to which this determination is being made (the “Interest Amount”).


 


(iv)        “Conversion
Commencement Date” means the first date, if at all, prior to the occurrence of a Share Authorization Default (as defined
in the Facility Agreement) on which the number of shares of Common Stock of the Company duly authorized for issuance under the
Company’s Certificate of Incorporation are sufficient to cover the issuance of all shares issuable upon a “Cash Exercise”
of all outstanding Warrants and conversion of all outstanding principal amounts under all Notes (regardless of whether such exercises
or conversions actually occur).


 




    	2



    	 



    

 


(v)         “Conversion
Price” means, as of any Conversion Date or other date of determination, [LESSER OR $.057 OR LAST BID ON DATE OF CLOSING,
BUT NO LESS THAN 93% OF THE LAST SALE ON DATE OF CLOSING] per Share, subject to adjustment as provided herein and subject to
appropriate adjustment to reflect any subdivision of outstanding Common Stock (by any stock split, stock dividend, recapitalization
or otherwise) or combination of outstanding Common Stock (by combination, reverse stock split or otherwise).


 


(vi)        “Dollars”
or “$” means United States Dollars.


 


(vii)       “Eligible
Market” means the NASDAQ Global Market, the NASDAQ Global Select Market, the New York Stock Exchange, the NYSE Alternext
or the Nasdaq Capital Market.


 


(viii)      “Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


(ix)         “Interest”
means any interest (including any default interest) accrued on the Principal pursuant to the terms of this Note and the Facility
Agreement.


 


(x)          “Issuance
Date” means March 31, 2014, regardless of any exchange or replacement hereof.


 


(xi)         “Major
Transaction” means any of the following events:


 


(A)         a
consolidation, merger, exchange of shares, recapitalization, reorganization, business combination or other similar event, (1) following
which the holders of Common Stock immediately preceding such consolidation, merger, exchange, recapitalization, reorganization,
combination or event either (a) no longer hold a majority of the shares of Common Stock or (b) no longer have the ability to elect
a majority of the board of directors of the Company or (2) as a result of which shares of Common Stock shall be changed into (or
the shares of Common Stock become entitled to receive) the same or a different number of shares of the same or another class or
classes of stock or securities of the Company or another entity (collectively, a “Change of Control Transaction”);


 


(B)         the
sale or transfer of (i) all or substantially all of the assets of the Company or (ii) assets of the Company for a purchase price
equal to more than 50% of the Enterprise Value (as defined below) of the Company. For purposes of this clause (B), “Enterprise
Value” shall mean (I) the product of (x) the number of issued and outstanding shares of Common Stock on the date the
Company delivers the Major Transaction Notice (as defined below in Section 3(b)) multiplied by (y) the per share closing price
of the Common Stock on such date plus (II) the amount of the Company’s debt as shown on the latest financial statements filed
with the SEC (the “Current Financial Statements”) less (III) the amount of cash and cash equivalents of the
Company as shown on the Current Financial Statements;


 




    	3



    	 



    

 


(C)         a
purchase, tender or exchange offer made to the holders of outstanding shares of Common Stock, such that following such purchase,
tender or exchange offer a Change of Control Transaction shall have occurred;


 


(D)         an
issuance or series of issuances by the Company after the date of this Note, of an aggregate number of shares of Common Stock, other
than shares issued upon exercise of the Warrants or conversion of, or payment of interest on, the Notes, in excess of 40% of the
Company’s outstanding Common Stock as of the date of such issuance;


 


(E)         the
liquidation, bankruptcy, insolvency, dissolution or winding-up (or the occurrence of any analogous proceeding) affecting the Company;


 


(F)         the
Common Stock ceases to be registered under Section 12 of the Exchange Act; or


 


(G)         after
being listed, traded or quoted on an Eligible Market, the shares of Common Stock cease to be listed, traded or publicly quoted
on such Eligible Market and are not promptly re-listed on an Eligible Market.


 


(xii)        “Principal”
means the outstanding principal amount of this Note as of any date of determination.


 


(xiii)       “Registration
Failure” means that (A) the Company fails to file with the SEC on or before the Filing Deadline (as defined in the Registration
Rights Agreement) any Registration Statement required to be filed pursuant to Section 2(a) of the Registration Rights Agreement
registering Conversion Shares, (B) the Company fails to obtain effectiveness with the SEC, prior to the Registration Deadline (as
defined in the Registration Rights Agreement), of any Registration Statements (as defined in the Registration Rights Agreement)
that are required to be filed pursuant to Section 2(a) of the Registration Rights Agreement registering Conversion Shares, or fails
to keep such Registration Statement current and effective as required in Section 3 of the Registration Rights Agreement, (C) the
Company fails to file any additional Registration Statements required to be filed pursuant to Section 2(a)(ii) of the Registration
Rights Agreement registering Conversion Shares on or before the Additional Filing Deadline or fails to cause such new Registration
Statement to become effective on or before the Additional Registration Deadline, (D) the Company fails to file any amendment to
any Registration Statement registering Conversion Shares, or any additional Registration Statement required to be filed pursuant
to Section 3(b) of the Registration Rights Agreement registering Conversion Shares within twenty (20) days of the applicable Registration
Trigger Date (as defined in the Registration Rights Agreement), or fails to cause such amendment and/or new Registration Statement
to become effective within sixty (60) days of the applicable Registration Trigger Date, (E) any Registration Statement required
to be filed under the Registration Rights Agreement registering Conversion Shares, after its initial effectiveness and during the
Registration Period (as defined in the Registration Rights Agreement), lapses in effect or sales of any Conversion Shares constituting
Registrable Securities (as defined in the Registration Rights Agreement) cannot otherwise be made thereunder (whether by reason
of the Company’s failure to amend or supplement the prospectus included therein in accordance with the Registration Rights
Agreement, the Company’s failure to file and to obtain effectiveness with the SEC of an additional Registration Statement
registering Conversion Shares or amended Registration Statement required pursuant to Sections 2(a)(ii) or 3(b) of the Registration
Rights Agreement, as applicable, or otherwise), and (F) the Company fails to provide a commercially reasonable written response
to any comments to the foregoing Registration Statements submitted by the SEC within twenty (20) days of the date that such SEC
comments are received by the Company.


 




    	4



    	 



    

 


(xiv)      “Registration
Rights Agreement” means that certain Registration Rights Agreement, dated as of March 31, 2014, by and among the Company
and the investors party to the Securities Purchase Agreement.


 


(xv)       “Required
Note Holders” means Holders of at least 50% in interest of the Notes.


 


(xvi)      “Securities
Act” means the Securities Act of 1933, as amended.


 


(xvii)     “Shares”
means shares of Common Stock.


 


(xviii)    “Trading
Day” means any day on which the Common Stock is traded for any period on the principal securities exchange or other securities
market or quotation system on which the Common Stock is then being traded.


 


(xix)       “Volume
Weighted Average Price” for any security as of any date means the volume weighted average sale price of such security
on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg Financial
Markets or an equivalent, reliable reporting service mutually acceptable to and hereinafter designated by the Required Note Holders
and the Company (“Bloomberg”) or, if no volume weighted average sale price is reported for such security, then
the last closing trade price of such security as reported by Bloomberg, or, if no last closing trade price is reported for such
security by Bloomberg, the average of the bid prices of any market makers for such security that are listed in the over the counter
market by the Financial Industry Regulatory Authority, Inc. or on the “over the counter” Bulletin Board (or any successor)
or in the “pink sheets” (or any successor) by the OTC Markets Group, Inc. If the Volume Weighted Average Price cannot
be calculated for such security on such date in the manner provided above, the Volume Weighted Average Price shall be the fair
market value as mutually determined by the Company and the Holders of a majority in interest of the Notes being converted for which
the calculation of the Volume Weighted Average Price is required in order to determine the Conversion Price of such Notes.


 


(xx)        “Warrants”
means the warrants issued by the Company pursuant to the Facility Agreement.


 




    	5



    	 



    

 


2.          Conversion
Rights. This Note may be converted into Shares on the terms and conditions set forth in this Section 2.


 


(a)          Conversion
at Option of the Holder. On or after the Conversion Commencement Date, the Holder shall be entitled to convert all or any part
of the Principal (and the Interest Amount thereon) or any Interest accrued hereunder into fully paid and nonassessable Shares (the
“Conversion Shares”) in accordance with this Section 2 at the Conversion Rate (as defined in Section
2(b)). The Company shall not issue any fraction of a Share upon any conversion. If the issuance would result in the issuance
of a fraction of a Share, then the Company shall round such fraction of a Share up or down to the nearest whole share (with 0.5
rounded up). Notwithstanding anything herein to the contrary, the Company shall not issue to the Holder, and the Holder may not
acquire, a number of Shares upon conversion of this Note or otherwise issue any shares of Common Stock pursuant hereto or the Facility
Agreement to the extent that, upon such conversion, the number of Shares then beneficially owned by the Holder and its Affiliates
and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes
of Section 13(d) of the Exchange Act (including shares held by any “group” of which the Holder is a member, but excluding
shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the
right to convert, exercise or purchase similar to the limitation set forth herein) would exceed 9.985% of the total number of shares
of Common Stock then issued and outstanding (the “9.985% Cap”), provided, however, that the 9.985% Cap shall
only apply to the extent that the Common Stock is deemed to constitute an “equity security” pursuant to Rule 13d-1(i)
promulgated under the Exchange Act. For purposes hereof, “group” has the meaning set forth in Section 13(d) of the
Exchange Act and applicable regulations of the Securities and Exchange Commission (“SEC”), and the percentage
held by the Holder shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act. Upon the
written request of the Holder, the Company shall, within two (2) Trading Days, confirm orally and in writing to the Holder the
number of Shares then outstanding.


 


(b)          Conversion
Rate. The number of Conversion Shares issuable upon a conversion of any portion of this Note pursuant to Section 2 shall
be determined according to the following formula (the “Conversion Rate”):


_______Conversion Amount_______


 Conversion Price


 


(c)          Mechanics
of Conversion. The conversion of this Note shall be conducted in the following manner:


 


(i)          Holder’s
Delivery Requirements. To convert a Conversion Amount into Conversion Shares on any date (the “Conversion Date”),
the Holder shall (A) transmit by facsimile or electronic mail (or otherwise deliver), for receipt on or prior to 5:00 p.m.
New York City time on such date, a copy of an executed conversion notice in the form attached hereto as Exhibit A (the “Conversion
Notice”) to the Company (Attention: Steven A. Shallcross, 209 Perry Parkway, Suite 7, Gaithersburg, MD 20877,
Fax: (240) 299-2690, Email: [____________]), and (B) if required by Section 2(c)(vi), surrender to a common
carrier for delivery to the Company, no later than three (3) Business Days after the Conversion Date, the original Note being converted
(or an indemnification undertaking in customary form with respect to this Note in the case of its loss, theft or destruction).


 




    	6



    	 



    

 


(ii)         Company’s
Response. Upon receipt or deemed receipt by the Company of a copy of a Conversion Notice, the Company (I) shall immediately
send, via facsimile, a confirmation of receipt of such Conversion Notice to the Holder and the Company’s designated transfer
agent (the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to process
such Conversion Notice in accordance with the terms herein and (II) on or before the second (2nd) Business Day following
the date of receipt or deemed receipt by the Company of such Conversion Notice (the “Share Delivery Date”) (A)
provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”) Fast Automated Securities
Transfer Program and provided that the Holder is eligible to receive Shares through DTC, credit such aggregate number of Conversion
Shares to which the Holder shall be entitled to the Holder’s or its designee’s balance account with DTC through its
Deposit Withdrawal Agent Commission system, or (B) if the foregoing shall not apply, issue and deliver to the address as specified
in the Conversion Notice, a stock certificate, registered in the name of the Holder or its designee, for the number of Conversion
Shares to which the Holder shall be entitled. If this Note is submitted for conversion, as may be required by Section 2(c)(vi),
and the Principal represented by this Note is greater than the Principal being converted, then the Company shall, as soon as practicable
and in no event later than three (3) Business Days after receipt of this Note (the “Note Delivery Date”) and
at its own expense, issue and deliver to the Holder a new Note representing the Principal not converted and cancel this Note. This
Note and the Conversion Shares will be free-trading, and freely transferable, and will not contain a legend restricting the resale
or transferability of the Conversion Shares if the Unrestricted Conditions (as defined below) are met.


 


(iii)        Dispute
Resolution. In the case of a dispute as to the determination of the Conversion Price or the arithmetic calculation of the Conversion
Rate, the Company shall instruct the Transfer Agent to issue to the Holder the number of Conversion Shares that is not disputed
and shall transmit an explanation of the disputed determinations or arithmetic calculations to the Holder via facsimile within
two (2) Business Days of receipt or deemed receipt of the Holder’s Conversion Notice or other date of determination. If the
Holder and the Company are unable to agree upon the determination of the Conversion Price or arithmetic calculation of the Conversion
Rate within one (1) Business Day of such disputed determination or arithmetic calculation being transmitted to the Holder, then
the Company shall promptly (and in any event within two (2) Business Days) submit via facsimile (A) the disputed determination
of the Conversion Price to an independent, reputable investment banking firm agreed to by the Company and the Required Note Holders,
or (B) the disputed arithmetic calculation of the Conversion Rate to the Company’s independent registered public accounting
firm, as the case may be. The Company shall direct the investment bank or the accounting firm, as the case may be, to perform the
determinations or calculations and notify the Company and the Holder of the results no later than two (2) Business Days from the
time it receives the disputed determinations or calculations. Such investment bank’s or accounting firm’s determination
or calculation, as the case may be, shall be binding upon all parties absent manifest error.


 




    	7



    	 



    

 


(iv)        Record
Holder. The person or persons entitled to receive the Conversion Shares issuable upon a conversion of this Note shall be treated
for all purposes as the legal and record holder or holders of such Shares upon delivery of the Conversion Notice via facsimile,
electronic mail or otherwise in accordance with the terms hereof.


 


(v)         Company’s
Failure to Timely Convert.


 


(A)         Cash
Damages. If within three (3) Business Days after the Company’s receipt of the facsimile or electronic mail copy of a
Conversion Notice or deemed receipt of a Conversion Notice the Company shall fail to issue and deliver a certificate to the Holder
for, or credit the Holder’s or its designee’s balance account with DTC with, the number of Conversion Shares (free
of any restrictive legend if the Unrestricted Conditions (as defined below) are met) to which the Holder is entitled upon the Holder’s
conversion of any Conversion Amount, or if the Company fails to issue and deliver a new Note representing the Principal to which
such Holder is entitled on or before the Note Delivery Date pursuant to Section 2(c)(ii), then in addition to all other
available remedies that the Holder may pursue hereunder and under the Facility Agreement, the Company shall pay additional damages
to the Holder for each day after the Share Delivery Date such conversion is not timely effected and/or each day after the Note
Delivery Date such Note is not delivered in an amount equal to one percent (1%) of the sum of the following: (a) in the event the
Company has failed to deliver the Conversion Shares to the Holder or its designee on or prior to the Share Delivery Date, the product
of (I) the number of Conversion Shares not issued to the Holder or its designee on or prior to the Share Delivery Date and to which
the Holder is entitled and (II) the Volume Weighted Average Price of the Common Stock on the Share Delivery Date (such product
is referred to herein as the “Share Product Amount”), and (b) in the event the Company has failed to deliver
a Note to the Holder on or prior to the Note Delivery Date, the product of (y) the number of Conversion Shares issuable upon conversion
of the Principal represented by the Note to have been delivered as of the Note Delivery Date and (z) the Volume Weighted Average
Price of the Common Stock on the Note Delivery Date. Alternatively, subject to Section 2(c)(iii), at the election of the
Holder made in the Holder’s sole discretion, the Company shall pay to the Holder, in lieu of the additional damages referred
to in the preceding sentence (but in addition to all other available remedies that the Holder may pursue hereunder and under the
Facility Agreement), 115% of the amount by which (A) the Holder’s total purchase price (including brokerage commissions,
if any) for the Shares purchased to make delivery in satisfaction of a sale by the Holder of the Conversion Shares to which the
Holder is entitled but has not received upon a conversion exceeds (B) the net proceeds received by the Holder from the sale of
the Shares to which the Holder is entitled but has not received upon such conversion. If the Company fails to pay the additional
damages set forth in this Section 2(c)(v)(A) within five (5) Business Days of the date incurred, then the Holder entitled
to such payments shall have the right at any time, so long as the Company continues to fail to make such payments, to require the
Company, upon written notice, to immediately issue, in lieu of such cash damages, the number of Shares equal to the quotient of
(X) the aggregate amount of the damages payments described herein divided by (Y) the Conversion Price in effect on such Conversion
Date as specified by the Holder in the Conversion Notice.


 




    	8



    	 



    

 


(B)         Void
Conversion Notice. If for any reason the Holder has not received all of the Conversion Shares prior to the tenth (10th) Business
Day after the Share Delivery Date with respect to a conversion of this Note (a “Conversion Failure”), then the
Holder, upon written notice to the Company (a “Void Conversion Notice”), may void its Conversion Notice with
respect to, and retain or have returned, as the case may be, any portion of this Note that has not been converted pursuant to the
Holder’s Conversion Notice; provided, that the voiding of the Holder’s Conversion Notice shall not affect the
Company’s obligations to make any payments that have accrued prior to the date of such notice pursuant to Section 2(c)(v)(A)
or otherwise.


 


(C)         Event
of Default. A Conversion Failure shall constitute an Event of Default under the Facility Agreement and entitle the Lenders
to all payments and remedies provided under the Facility Agreement upon the occurrence of an Event of Default.


 


(vi)        Book-Entry.
Notwithstanding anything to the contrary set forth herein, upon conversion or redemption of this Note in accordance with the terms
hereof, the Holder shall not be required to physically surrender this Note to the Company unless all of the Principal is being
converted or redeemed. The Holder and the Company shall maintain records showing the Principal converted or redeemed and the dates
of such conversions or redemptions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as
not to require physical surrender of this Note upon any such partial conversion or redemption. Notwithstanding the foregoing, if
this Note is converted or redeemed as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders
this Note to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note of like
tenor, registered as the Holder may request, representing in the aggregate the remaining Principal represented by this Note. The
Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph,
following conversion or redemption of any portion of this Note, the Principal of this Note may be less than the principal amount
stated on the face hereof.


 


(d)          Taxes.
The Company shall pay any and all taxes (excluding income taxes, franchise taxes or other taxes levied on gross earnings, profits
or the like of the Holder) that may be payable with respect to the issuance and delivery of Conversion Shares upon the conversion
of this Note.


 


(e)          Legends.


 


(i)          Restrictive
Legend. The Holder understands that until such time as this Note or the Conversion Shares have been registered under the Securities
Act as contemplated by the Registration Rights Agreement or otherwise may be sold pursuant to Rule 144 under the Securities Act
or an exemption from registration under the Securities Act without any restriction as to the number of securities as of a particular
date that can then be immediately sold, this Note and the Conversion Shares, as applicable, may bear a restrictive legend in substantially
the following form (and a stop-transfer order may be placed against transfer of the certificates for such securities):


 




    	9



    	 



    

 


“THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING, WITHOUT LIMITATION,
PURSUANT TO RULES 144 OR 144A UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION
OR GUIDANCE, SUCH AS A SO-CALLED “4(1) AND A HALF” SALE.”


 


“THE SALE, TRANSFER OR ASSIGNMENT OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN REGISTRATION RIGHTS AGREEMENT DATED AS OF
MARCH __, 2014, AS AMENDED FROM TIME TO TIME, AMONG THE COMPANY AND CERTAIN HOLDERS OF ITS OUTSTANDING SECURITIES. COPIES OF SUCH
AGREEMENT MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE
COMPANY.”


 


(ii)         Removal
of Restrictive Legends. This Note and the certificates evidencing the Conversion Shares, as applicable, shall not contain any
legend restricting the transfer thereof (including the legend set forth above in subsection 2(e)(i)): (A) while a registration
statement (including a Registration Statement, as defined in the Registration Rights Agreement) covering the sale or resale of
such security is effective under the Securities Act, or (B) following any sale of such Note and/or Conversion Shares pursuant to
Rule 144, or (C) if such Note or Conversion Shares, as the case may be, are eligible for sale under Rule 144(b)(1), or (D) if such
legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the SEC) (collectively, the “Unrestricted Conditions”). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent promptly after the Effective Date (as defined below), or at such other time as the
Unrestricted Conditions have been satisfied, if required by the Company’s transfer agent to effect the issuance of this Note
or the Conversion Shares, as applicable, without a restrictive legend or removal of the legend hereunder. If the Unrestricted Conditions
are met at the time of issuance of the Conversion Shares, then the Conversion Shares shall be issued free of all legends. The Company
agrees that following the Effective Date or at such time as the Unrestricted Conditions are met or such legend is otherwise no
longer required under this Section 2(e), it will, no later than three (3) Trading Days following the delivery (the “Unlegended
Shares Delivery Deadline”) by the Holder to the Company or the Transfer Agent of this Note and a certificate representing
Conversion Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend Removal Date”),
deliver or cause to be delivered to such Holder this Note and/or a certificate (or electronic transfer) representing such shares
that is free from all restrictive and other legends. For purposes hereof, “Effective Date” shall mean the date
that the Registration Statement that the Company is required to file pursuant to the Registration Rights Agreement has been declared
effective by the SEC.


 




    	10



    	 



    

 


(iii)        Sale
of Unlegended Shares. Holder agrees that the removal of the restrictive legend from this Note and any certificates representing
securities as set forth in Section 2(e) above is predicated upon the Company’s reliance that the Holder will sell
this Note or any Conversion Shares, as applicable, pursuant to either the registration requirements of the Securities Act, including
any applicable prospectus delivery requirements, or an exemption therefrom, and that if such securities are sold pursuant to a
Registration Statement, they will be sold in compliance with the plan of distribution set forth therein.


 


3.          Rights
Upon Major Transaction. In the event that a Major Transaction occurs, then the Holder, at its option, may require the Company
to redeem the Principal Amount outstanding on the Holder’s Notes in accordance with Section 3(b) below. In the event
the Holder shall not have exercised any of its rights under the immediately preceding sentence above within the applicable time
periods set forth herein, then the Major Transaction shall be treated as an Assumption (as defined below) in accordance with Section
3(a) below unless the Holder waives its rights under this Section 3 with respect to such Major Transaction.


 


(a)          Assumption.
In addition to any other rights provided to the Holder hereunder, under the Facility Agreement or otherwise, prior to the consummation
of any Major Transaction that is to be treated as an Assumption pursuant to this Section 3, the Company will secure from
the Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such Major Transaction
(in each case, the “Successor Entity”) a written agreement, in form and substance reasonably satisfactory to
the Required Note Holders and approved by the Required Note Holders (which approval shall not be unreasonably withheld), to deliver
to the Holder in exchange for this Note, a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Note and reasonably satisfactory to the Required Note Holders and approved by the Required Note Holders
(which approval shall not be unreasonably withheld), which instrument shall have a principal amount and interest rate equal to
the Principal and the interest rate of the Note, have similar ranking and have similar conversion rights, provided that
such new instrument shall ensure (in a manner reasonably satisfactory to the Required Note Holders) that the Holder will thereafter
have the right to acquire and receive, in lieu of or in addition to (as the case may be) the Shares immediately theretofore acquirable
and receivable upon the conversion of this Note (without regard to any limitations or restrictions on conversion), such shares
of stock, securities or assets of the Successor Entity that would have been issued or payable in such Major Transaction with respect
to or in exchange for the number of Shares that would have been acquirable and receivable upon the conversion of this Note as of
the date of such Major Transaction (without taking into account any limitations or restrictions on the conversion of this Note).
Prior to the consummation of any other Major Transaction, the Company shall make appropriate provision (in form and substance reasonably
satisfactory to the Required Note Holders and approved by the Required Note Holders (which approval shall not be unreasonably withheld))
to ensure that the Holder will thereafter have the right to acquire and receive, in lieu of or in addition to (as the case may
be) the Shares immediately theretofore acquirable and receivable upon the conversion of this Note (without regard to any limitations
or restrictions on conversion), such shares of stock, securities or assets that would have been issued or payable in such Major
Transaction with respect to or in exchange for the number of Shares that would have been acquirable and receivable upon the conversion
of this Note as of the date of such Major Transaction (without taking into account any limitations or restrictions on the conversion
of this Note). Any assumption of Company obligations under this paragraph shall be referred to herein as an “Assumption.”


 




    	11



    	 



    

 


(b)          Notice;
Major Transaction Early Termination Right. At least thirty (30) days prior to the consummation of any Major Transaction, but,
in any event, within five (5) Business Days following the first to occur of (x) the date of the public announcement of such Major
Transaction if such announcement is made before 4:00 p.m., New York City time, or (y) the day following the public announcement
of such Major Transaction if such announcement is made on and after 4:00 p.m., New York City time, the Company shall deliver written
notice thereof via facsimile and overnight courier to the Holder (a “Major Transaction Notice”). At any time
during the period beginning after the Holder’s receipt of a Major Transaction Notice and ending five (5) Trading Days prior
to the consummation of such Major Transaction (the “Early Termination Period”), the Holder may require the Company
to redeem (an “Early Termination Upon Major Transaction”) all or any portion of this Note (without taking into
consideration the 9.985% Cap or whether the Conversion Commencement Date has occurred) by delivering written notice thereof (“Major
Transaction Early Termination Notice”) to the Company, which Major Transaction Early Termination Notice shall indicate
the portion of the Note (the “Early Termination Amount”), calculated with reference to the number of Shares
into which such portion is convertible relative to the total number of shares into which the Note is convertible, that the Holder
is electing to have redeemed. The portion of this Note subject to early termination pursuant to this Section 3(b) (the “Redeemable
Shares”), shall be redeemed by the Company at a price (the “Major Transaction Note Early Termination Price”)
payable in cash equal to the “Black Scholes Value” of the Redeemable Shares determined by use of the Black Scholes
Option Pricing Model using the criteria set forth in Schedule 1 hereto (the “Black Scholes Value”).


 


(c)          Escrow;
Payment of Major Transaction Note Early Termination Price. Following the receipt of a Major Transaction Early Termination Notice
from the Holder, the Company shall not effect a Major Transaction that is being treated as an early termination unless either (i)
it obtains the written agreement of the Successor Entity that payment of the Major Transaction Note Early Termination Price shall
be made to the Holder prior to consummation of such Major Transaction and such payment shall be a condition precedent to consummation
of such Major Transaction or (ii) it shall first place into an escrow account with an independent escrow agent, at least three
(3) business days prior to the closing date of the Major Transaction (the “Major Transaction Escrow Deadline”),
an amount in cash, equal to the Major Transaction Note Early Termination Price. Concurrently upon closing of such Major Transaction,
the Company shall pay or shall instruct the escrow agent to pay the Major Transaction Note Early Termination Price. For purposes
of determining the amount required to be placed in escrow pursuant to the provisions of this subsection (c) and without affecting
the amount of the actual Major Transaction Note Early Termination Price, the calculation of the price referred to in clause (1)
of the first column of Schedule 1 hereto with respect to Stock Price shall be determined based on the Closing Market Price (as
defined on Schedule 1) of the Common Stock on the Trading Day immediately preceding the date that the funds are deposited with
the escrow agent.


 




    	12



    	 



    

 


(d)          Injunction.
Following the receipt of a Major Transaction Early Termination Notice from the Holder, in the event that the Company attempts to
consummate a Major Transaction without either (i) placing the Major Transaction Note Early Termination Price in escrow in accordance
with subsection (c) above, (ii) payment of the Major Transaction Note Early Termination Price to the Holder prior to consummation
of such Major Transaction or (iii) obtaining the written agreement of the Successor Entity described in subsection (c) above, the
Holder shall have the right to apply for an injunction in any state or federal courts sitting in the City of New York, borough
of Manhattan to prevent the closing of such Major Transaction until the Major Transaction Note Early Termination Price is paid
to the Holder, in full.


 


An early termination
required by this Section 3 shall have priority to payments to holders of Common Stock in connection with a Major Transaction,
and to the extent an early termination required by this Section 3 is deemed or determined by a court of competent jurisdiction
to be prepayments of the Note by the Company, such early termination shall be deemed to be voluntary prepayments. Notwithstanding
anything to the contrary in this Section 3, until the Major Transaction Note Early Termination Price is paid in full, this
Note may be converted, in whole or in part, by the Holder into Shares, or in the event the Conversion Date is after the consummation
of the Major Transaction, shares of publicly traded common stock (or their equivalent) of the Successor Entity pursuant to this
Section 3. The parties hereto agree that in the event of the early termination of any portion of the Note under this Section
3, the Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict
future interest rates and the uncertainty of the availability of a suitable substitute investment opportunity for the Holder. Accordingly,
any premium due under this Section 3 is intended by the parties to be, and shall be deemed, a reasonable estimate of the
Holder’s actual loss of its investment opportunity and not as a penalty.


 


4.          Registration
Failures. Upon any Registration Failure, in addition to all other available remedies that the Holder may pursue hereunder and
under the Facility Agreement, the Registration Rights Agreement and the Warrants, the Company shall pay additional damages to the
Holder for each 30-day period (prorated for any partial period) after the date of such Registration Failure in an amount in cash
equal to two percent (2%) of such Holder’s original principal amount of this Note on the date of such Registration Failure.
Such payments shall accrue until the earlier of (i) such time as the Registration Failure has been cured and (ii) the date on which
all of the Conversion Shares may be sold without restriction under Rule 144 (including, without limitation, volume restrictions
and without the need for the availability of current public information under Rule 144). All such payments that accrue under this
Section (4) shall be payable no later than five business days following such date of accrual.


 


5.          Voting
Rights. Except as required by law, the Holder shall have no voting rights with respect to any of the Conversion Shares until
the Conversion Date relating to the conversion of this Note upon which such Conversion Shares are issuable (or in the case of Conversion
Shares the issuance of which is subject to a bona fide dispute that is subject to and being resolved pursuant to, and in
compliance with the time periods and other provisions of, the dispute resolution provisions of Section 2(c)(iii), the first
Business Day after the resolution of such bona fide dispute).


 




    	13



    	 



    

 


6.          Amendment;
Waiver. The terms and provisions of this Note shall not be amended or waived except in a writing signed by the Company and
the Holder.


 


7.          Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall be cumulative
and in addition to all other remedies available under this Note, the Facility Agreement, at law or in equity (including a decree
of specific performance and/or other injunctive relief). No remedy contained herein shall be deemed a waiver of compliance with
the provisions giving rise to such remedy, and nothing herein shall limit the Holder’s right to pursue actual damages for
any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
conversion and the like (and the computation thereof) shall be the amounts to be received by the Holder thereof and shall not,
except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at
law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach,
the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the
necessity of showing economic loss and without any bond or other security being required.


 


8.          Specific
Shall Not Limit General; Construction. No specific provision contained in this Note shall limit or modify any more general
provision contained herein. This Note shall be deemed to be jointly drafted by the Company and all purchasers of Notes pursuant
to the Facility Agreement and shall not be construed against any Person as the drafter hereof.


 


9.          Failure
or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other
or further exercise thereof or of any other right, power or privilege.


 


10.         Notices.
Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice shall be given in accordance
with Section 6.1 of the Facility Agreement.


 


11.         Restrictions
on Transfer.


 


(a)          Registration
or Exemption Required. This Note has been issued in a transaction exempt from the registration requirements of the Securities
Act by virtue of Regulation D. None of the Note or the Conversion Shares may be pledged, transferred, sold, assigned, hypothecated
or otherwise disposed of except pursuant to an effective registration statement or an exemption to the registration requirements
of the Securities Act and applicable state laws including, without limitation, a so-called “4(1) and a half” transaction.


 




    	14



    	 



    

 


(b)          Assignment.
Subject to Section 11(a), the Holder may sell, transfer, assign, pledge, hypothecate or otherwise dispose of this Note,
in whole or in part. Holder shall deliver a written notice to Company, substantially in the form of the Assignment attached hereto
as Exhibit B, indicating the Person or Persons to whom the Note shall be assigned and the respective principal amount of
the Note to be assigned to each assignee. The Company shall effect the assignment within three (3) business days (the “Transfer
Delivery Period”), and shall deliver to the assignee(s) designated by Holder a Note or Notes of like tenor and terms
for the appropriate principal amount. This Note and the rights evidenced hereby shall inure to the benefit of and be binding upon
the successors and assigns of the Holder. The provisions of this Note are intended to be for the benefit of all Holders from time
to time of this Note, and shall be enforceable by any such Holder. For avoidance of doubt, in the event Holder notifies the Company
that such sale or transfer is a so called “4(1) and half” transaction, the parties hereto agree that a legal opinion
from outside counsel for the Holder delivered to counsel for the Company substantially in the form attached hereto as Exhibit
C shall be the only requirement to satisfy an exemption from registration under the Securities Act to effectuate such “4(1)
and half” transaction.


 


12.         Payment
of Collection, Enforcement and Other Costs. If (a) this Note is placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding; or (b) an attorney is retained to represent the Holder in any bankruptcy,
reorganization, receivership of the Company or other proceedings affecting Company creditors’ rights and involving a claim
under this Note, then the Company shall pay the costs incurred by the Holder for such collection, enforcement or action, including
reasonable attorneys’ fees and disbursements.


 


13.         Cancellation.
After all Principal, Interest and other amounts at any time owed under, or on account of, this Note have been paid in full or converted
into Shares in accordance with the terms hereof, this Note shall automatically be deemed cancelled, shall be surrendered to the
Company for cancellation and shall not be reissued.


 


14.         Registered
Note. In order to qualify as a “registered note” for purposes of the Code, transfer of this Note may be effected
only by (i) surrender of this Note to the Company and the re-issuance of this Note to the transferee, or the Company’s issuance
to the Holder of a new note in the same form as this Note but with the transferee denoted as the Holder, or (ii) the recording
of the identity of the transferee by the Affiliate of the Holder that is maintaining a record ownership register of this Note as
a non-fiduciary agent of, and on behalf of, the Company for the tax purposes set forth herein. Such Affiliate in its capacity as
such agent shall notify the Company in writing immediately upon any change in such identity. Any attempted transfer in violation
of the relevant provisions of this Note shall be void and of no force and effect. Until there has been a valid transfer of this
Note and of all of the rights hereunder by the Holder in accordance with this Note, the Company shall deem and treat the Holder
as the absolute beneficial owner and holder of this Note and of all of the rights hereunder for all purposes (including, without
limitation, for the purpose of receiving all payments to be made under this Note).


 




    	15



    	 



    

 


15.         Waiver
of Notice. To the extent permitted by law, the Company hereby waives demand, notice, presentment, protest and all other demands
and notices in connection with the delivery, acceptance, performance, default or enforcement of this Note and the Facility Agreement.


 


16.         Governing
Law. This Note shall be construed and enforced in accordance with, and all questions concerning the construction, validity,
interpretation and performance of this Note and all disputes arising hereunder shall be governed by, the laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any
other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. The Company
(a) agrees that any legal action or proceeding with respect to this Note or any other agreement, document, or other instrument
executed in connection herewith, shall be brought exclusively in any state or federal court located within New York, New York,
(b) irrevocably waives any objections which the Company may now or hereafter have to the venue of any suit, action or proceeding
arising out of or relating to this Note, or any other agreement, document, or other instrument executed in connection herewith,
brought in the aforementioned courts, (c) further irrevocably waives any claim that any such suit, action, or proceeding brought
in any such court has been brought in an inconvenient forum and (d) hereby consents that personal service of summons or other legal
process may be made as set forth in Section 5.4 of the Facility Agreement. EACH OF THE COMPANY AND THE HOLDER (BY ACCEPTANCE HEREOF)
IRREVOCABLY WAIVES THE RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING BROUGHT TO ENFORCE ANY PROVISION OF THIS NOTE OR ANY
OTHER TRANSACTION DOCUMENT.


 


17.         Interpretative
Matters. Unless the context otherwise requires, (a) all references to Sections or Exhibits are to Sections or Exhibits contained
in or attached to this Note, (b) each accounting term not otherwise defined in this Note has the meaning assigned to it in accordance
with GAAP, (c) words in the singular or plural include the singular and plural and pronouns stated in either the masculine, the
feminine or neuter gender shall include the masculine, feminine and neuter and (d) the use of the word “including”
in this Note shall be by way of example rather than limitation. If a stock split, stock dividend, stock combination or other similar
event occurs during any period over which an average price is being determined, then an appropriate adjustment will be made to
such average to reflect such event.


 


18.         Execution.
A facsimile, telecopy, PDF or other reproduction of this Note may be delivered by the Company, and an executed copy of this Note
may be delivered by the Company by facsimile, e-mail or other similar electronic transmission device pursuant to which the signature
of or on behalf of the Company can be seen, and such execution and delivery shall be considered valid, binding and effective for
all purposes. The Company hereby agrees that it shall not raise the execution of facsimile, PDF or other reproduction of this Note,
or the fact that any signature was transmitted by facsimile, e-mail or other similar electronic transmission device, as a defense
to the Company’s execution of this Note. Notwithstanding the foregoing, the Company shall be required to deliver an originally
executed Note to the Holder.


 


[Signature page follows]


 




    	16



    	 



    

 


IN WITNESS WHEREOF,
the Company has caused this Note to be duly executed as of the date first set forth above.


 


	 	COMPANY:
	 	 
	 	CYTOMEDIX, INC.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 


 




    	17



    	 



    

 


Exhibit A


 


CONVERSION NOTICE


 


Reference is made to
the Senior Secured Convertible Note (the “Note”) of CYTOMEDIX, INC., a Delaware corporation (the “Company”),
in the original principal amount of $[__________]. In accordance with and pursuant to the Note, the undersigned hereby elects to
convert the Conversion Amount (as defined in the Note) of the Note indicated below into Shares of Common Stock, par value $0.0001
per share (the “Common Stock”), of the Company, as of the date specified below.


 


Date of Conversion: __________


 


Aggregate Conversion Amount to
be converted at the Conversion Price (as defined in the Note):


______________________________


 


Principal, applicable thereto, to be converted: _______________________________


 


Interest, applicable thereto,
to be converted: ____________________________


 


Please confirm the following information:


 


Conversion Price: ____________________________________________________


 


Number of shares of
Common Stock to be issued: ___________________________


 


Please issue the Common Stock into which
the Note is being converted in the following name and to the following address:


 


Issue to: ____________________________________________________________


 


Facsimile Number:
____________________________________________________


 


Authorization: ________________________


By: ___________________________


Title: __________________________


 


Dated: _______________________________


 


DTC Participant Number and
Name (if electronic book entry transfer): ____________


Account Number (if
electronic book entry transfer): __________________________


 




    	 



    	 



    

 


ACKNOWLEDGMENT


 


The Company hereby
acknowledges this Conversion Notice and hereby directs [TRANSFER AGENT] to issue the above indicated number of shares of Common
Stock in accordance with the Irrevocable Transfer Agent Instructions dated March [__], 2014 from the Company and acknowledged and
agreed to by [TRANSFER AGENT].


 


	 	CYTOMEDIX, INC.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 


 




    	 



    	 



    

 


Exhibit B


 


ASSIGNMENT


 


(To be executed by the registered holder

desiring to transfer the Note)


 


FOR VALUE RECEIVED, the undersigned holder of the attached Senior
Secured Convertible Note (the “Note”) hereby sells, assigns and transfers unto the person or persons below named
the right to receive the principal amount of $__________ from Cytomedix, Inc., a Delaware corporation, evidenced by the attached
Note and does hereby irrevocably constitute and appoint __________ attorney to transfer the said Note on the books of the Company,
with full power of substitution in the premises.


 


	Dated:  _______________	 	 
	 	 	Signature
	 	 	 
	Fill in for new registration of Note:	 	 
	 	 	 
	 	 	 
	Name	 	 
	 	 	 
	 	 	 
	Address	 	 
	 	 	 
	Please print name and address of assignee	 	 


 


(including zip code number)


 


NOTICE


 


The signature to the foregoing Assignment must correspond to
the name as written upon the face of the attached Note in every particular, without alteration or enlargement or any change whatsoever.


 




    	 



    	 



    

 


Exhibit C


 


FORM OF OPINION


 


______, 20__


 


[___________]


 


Re:Cytomedix, Inc. (the “Company”)


 


Dear Sir:


 


[___________] (“[__________]”) intends to transfer
its Senior Secured Convertible Note in the principal amount of $_______ (the “Note”) of the Company to __________ (“________”)
without registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection herewith, we
have examined such documents and issues of law as we have deemed relevant.


 


Based on and subject to the foregoing, we are of the opinion
that the transfer of the Note by _______ to ______ may be effected without registration under the Securities Act, provided, however,
that the Note to be transferred to _______ contain a legend restricting its transferability pursuant to the Securities Act and
that transfer of the Note is subject to a stop order.


 


The foregoing opinion is furnished only to ____________ and
may not be used, circulated, quoted or otherwise referred to or relied upon by you for any purposes other than the purpose for
which furnished or by any other person for any purpose, without our prior written consent.


 


Very truly yours,